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The aim of this study was to evaluate the genotoxicity of ionizing radiation on 
medical personnel using the micronucleus assay and to determine the human health 
risk. Paired Student’s t-test shows significant statistical difference between the total 
number of binucleated (BN) cells with micronuclei within the two groups (exposed 
and control) (t=6,812; p<0,05). The mean of MN frequencies in the exposed group 
increased in comparison with the mean of MN frequencies in the control group. The 
formation of small and large micronuclei indicates that medical personnel who are 
exposed on radiation in their work place, have a chromosomal instability and a risk of 
cancer.  
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INTRODUCTION 
           Chromosomal evaluation and cytogenetic monitoring are some of the most 
important methods for observation of the chronic exposure of organism to a potentially genotoxic 
agents, like drugs, chemical and physical agents, particularly the ionizing rays (COTTERILL et al., 
2001; GE, et al., 2005). Ionizing radiation and different physical and chemical agents can cause 
major alteration to the genetic material and other types of chromosomal instability and damage, or 
from the genetic point of view, they have chromosomal mutagenic effect. The micronucleus 
assay, like basic genotoxic test in molecular epidemiology and cytogenetics, is applied as 
diagnostic tool and procedure for measuring micronucleus (MN) frequency in peripheral blood 
lymphocytes (PBL). This assay is used for defining the muthagenethic effect of some genotoxic 
agents or bearing a susceptible genetic profile, like presence and extent of chromosomal damage 
in human populations (FENECH et al., 1999). The observation of DNA damage at chromosomal 
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level and genetic monitoring is becoming an integral part of preventive medical surveillance, 
because chromosomal mutation is the main reason for carcinogenesis. In this point of view, the 
MN assay is one of the methods for cytogenetic evaluation for both, chromosome loss and 
chromosome breakage (FENECH et al., 1999; FENECH, 2000). Also, the Cytokinesis-Blocked 
Micronucleus (CBMN) assay provides an analysis for the other abnormal nuclear shapes (ANS), 
like micronuclei (MNi), nucleoplasmic bridges (NPBs) and nuclear buds (NBUDs). These types 
of formations have been associated with mitotic and chromosomal instability (CAMPS et al., 
2005). CBMN is suitable and standardized test in genotoxicology used for assessment of 
genotoxicological effects of different chemical or physical agents and it is the most commonly 
used method for measuring DNA damage in human lymphocytes (FENECH, 1998; FENECH et al., 
1999; HESSEL et al., 2001). MNi originates from acentric fragments, whole chromatids or 
chromosomes and it is a result of chromosome breaks or spindle disruption (KIRSCH-VOLDERS et 
al., 1997, 2001, 2003; FENECH, 2005). The biological response of human tissues to radiation could 
be unpredictable and it is very complex, because many, even more complex chemical interactions 
can occur if two chemicals act in different, but related ways. In extreme cases, there may be 
synergistic effects, in which case the effects of two substances together are greater than the sum 
of either effect alone. 60Co is one of the radiation sources, which can cause various illnesses and 
deaths worldwide (CAO et al., 2013). Blood, like hematological tissue and principally 
lymphocytes are the most sensitive cells to ionizing radiation (BONASSI et al., 2003, 2007, 2011).  
The aim of this research was to evaluate and confirm the genotoxicity of ionizing 
radiation using the CBMN assay and to determine the human health risk. We analyzed the results 
of lymphocyte MNi, NPBs, NBUDs as biomarker of DNA miss repair complexes (FENECH, 2007) 
on the medical personnel occupationally exposed to ionizing radiation via control group. 
 
MATERIALS AND METHODS 
Study groups 
The study was approved by the Ethical Committee of the Faculty of medical science in 
“Goce Delcev” University in Stip, R. of Macedonia, and all subjects of the exposed and the 
control group provided their written consents, according to the Declaration of Helsinki (2013). 
The study population included (Table 1):  
- 20 individuals in the exposed group, medical personnel exposed to ionizing radiation 
(radiologist, technicians and nurses) and 
- 20 individuals in the control group, healthy people, (who have never been exposed to 
ionizing rays and other chemical or physical agents).  
All participants were informed about the aim of the study and they completed a 
comprehensive questionnaire about demographic information such as age, lifestyle factors 
(tobacco usage), profession, medical history and exposure to chemical, physical agents or 
radiotherapy. Blood samples were obtained during a routine annual checkup of health. 
Venous blood sample (3 ml) was collected in heparinized tubes by trained nurses from 
each individual of both exposed and control groups. Blood culture protocol was done according to 
Fenech, (5). Fresh blood was collected by venipuncture and transferred into sterile, heparinized 
vacutainers. 0.5-ml of blood sample was added to the culture tubes containing 4.5 ml of RPMI 
1640 media enriched with 20% fetal bovine serum, L-glutamine and 0.2 ml of 
phytohemagglutinin 1 % and eachsupplemented with 100 units/mL penicillin and 100 µg/mL 
streptomycin. The lymphocytes were cultured in 15 mL sterile plastic tubes with conical bottom 
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(Nunc), the tubes were mixed gently by invertingfor a few minutes and incubated (CO2 incubator 
for 24 hours) for 44h at 37 °C in a slant position. Cytochalasin B was then added to each culture 
at a concentration of 3 μg/ml to block cell cytokinesis and cultures were reincubated at 37 °C for 
further 28 h. Cells were then harvested by centrifugation at 1,000 rpm for 10 min. Supernatant 
was discarded by pipetting the media, leaving as little medium as possible over the cell pellet. 
Cell pellet was resuspended in the supernatant remains and 10 ml of 0.56% KCl warm hypotonic 
solution was added gently to each tube. Fixation was carried out during 2x15 minutes by fixative 
(glacial acetic acid: methanol = 1:3). Fixation steps were repeated for three more times. After that, 
the fixed lymphocyte cells were dropped from about 30 cm height using a Pasteur pipette onto 
microscopic slides. The slides were stained by 2% alkaline Giemsa for 8 minutes, then washed in 
distilled water and examined by light microscope Leica DM4500 P (×40 and×100). 
 
Table 1. Demographic characteristics of the study population (the exposed and the control group) 
 
RESULTS AND DISCUSSION 
The analyses of MN were carried out on 1000 BN lymphocites per patient. Additionally 
with the findings of these studies (FENECH, 2007; KIRSCH-VOLDERS et al., 2001) the authors 
classified the cells as mononucleates (Fig.1), binucleates (Fig.1 and Fig.2 a and b), or 
multinucleate (Fig.3 a and b). 
 
 
Fig. 1 Photomicrograph of mononucleated cell scored in CBMN assay 
 Exposed group Control group 
Number of men 13 10 
Number of women 7 10 
Age range 45±15 18±22 
Range of years of 
professional exposure 
15-35 / 
Smokers 13 7 
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a)                                                                                  b) 
                            
 
Fig. 2 Photomicrographs of BN cells scored in CBMN assay a) and b) 
 
 
         
           a)                                                                                  b) 
           
 
Fig. 3 Photomicrographs of multinucleated cells scored in CBMN assay a) and b) 
 
 
For each sample 1,000 BN cells were evaluated for the frequency of MN (Fig.4 a, b, c 
and d), NPBs (Fig.5 a and b) and NBUDs (Fig.6 a and b) in BN cells, according to FENECH, 
(2007). MNi are defined as small, round nuclei clearly separated from the main cell nucleus 
which forms from acentric chromosome fragments or whole chromosome(s) during cell division 
(Fig.4). Only cells with clearly visible cytoplasm and approximately similar-sized nuclei were 
analyzed. Slides were scored blindly using a Leica DM4500 P optical microscope. 
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a)         b)  
 
 
c)          d)  
Fig. 4 Photomicrographs of BN cells containing MN scored in CBMN assay a), b), c) and d) 
 a)       b) 
 
Fig. 5 Photomicrographs of BN cells containing NPB scored in CBMN assay a) and b) 
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a)               b) 
Fig. 6 Photomicrographs of BN cells containing NBUDs scored in CBMN assay a) and b) 
 
Cytogenetic analysis of peripheral blood lymphocytes showed that the number of BN 
cells, with one MN ranged from 5 to 23 in the exposed, and from 1 to 13 in the control group 
(Table 2). In both groups the most frequent micronucleated cells were the ones with one MN, the 
cells with two or three MNi were very rare. Student’s t-test showed significant statistical 
differences between the total number of BN cells with MNi within the two groups (the exposed 
and the control) (t=6,812; p<0,05).  
The observed MN frequencies were compared with the criteria for spontaneous MNi 
(4.4±2.6 per 500 BN cells) given by FENECH and MORLEY (1985, 1986). The authors confirme 
than in the exposed group, 12 individual samples (60 %) showed an increase in the MN frequency 
while in the control group, the increased frequency of MNi was found in 1 of the blood samples 
(5%). 10 subjects with increased MN frequency in the exposed group and 1 in the control group 
smoked tobacco. In other words, this study revealed that the increased number of MNi in the 
exposed group was more common in smokers. Moreover, the clear evidence of increased number 
of MN formation was in a smoking woman in the control group. In addition to age and gender, 
smoking habits may change the MN frequency. The very important factors which explain the 
evidence of MN in the lymphocytes are the years of the exposure and the age of the subjects, 
especially in the exposed group. The samples with long time of exposure on ionizing radiation 
have much more MNi than the other samples (Table 2). In both analyzed samples of women in 
the exposed and the control group, age represents serious factor for the MNi values. BONASSI et 
al. (2003) confirmed a significant effect of smoking on MN frequency but, the study’s of HESSEL 
et al. (2001) and COSTA et al. (2006) observed no relation between smoking habit and MN 
frequency. EL-ZEIN, et al. (2008) and GARAJ-VRHOVAC et al. (2008) assessed that genotoxic 
hazards from cigarettes cause cell changes or cell death. Although men dominated in the exposed 
group, all the women from this exposed group showed increased MN frequency (Table 2). In the 
control group, one subject with increased MN frequency was a woman. The results of the other 
study’s (FENECH, 1994) that also used CBMN assay, suggest that sex is an important factor for 
evaluation of the cytogenetic damage. The authors of the study, also found an enormously high 
frequency of MNi in control women in comparison with men in the same group. One woman in 
the control group (at age 40) used ordinary therapy on oral estrogen hormones for two years 
before the test and she had increased number of MN in the lymphocytes (Table 2).  
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Table 2. General characteristics, MNi frequency and MN distribution in male and female individuals in the 
exposed and the control group 
 
 
The fact that the frequency of MNi is greater in female with reproductive disorders is 
confirmed in another study (FENECH, 1994), that also indicated greater chromosomal instability in 
lymphocytes. Other study’s (THIERENS et al., 1999; 2000; JOSEPH et al., 2009) also assessed that 
the frequencies of MN are greater in females than in males. In this study the authors confirmed 
that two men in the exposed group, who have hypothyroidism (receive a therapy with euthyrox), 
have increased number of MNi (Table 2). In the research of AL FAISAL et al. (2012), there was an 
SAMPLE EXPOSED GROUP CONTROL GROUP 
1. M/F AGE  PROFES.EXPOS S/NS MN M/F  AGE S/NS MN 
2. M 60 32 S 16 M 21 NS 5 
3. M 51 24 S 12 M 19 NS 0 
4. M 50 15 NS 5 M 27 S 4 
5. F 59 35 S 18 M 18 NS 1 
6. F 45 15 S 21 M 33 S 8 
7. M 48 27 S 9 M 20 NS 2 
8. M 46 18 NS 14 M 25 NS 3 
9. M 45 17 NS 8 M 25 NS 2 
10. F 57 33 S 19 M 21 S 0 
11. M 45 16 NS 8 M 21 NS 2 
12. F 55 31 S 17 F 31 NS 2 
13. F 45 23 NS 21 F 28 NS 4 
14. M 45 26 S 8 F 28 NS 5 
15. F 60 35 S 18 F 28 S 3 
16. M 58 24 S 16 F 32 S 11 
17. M 46 16 S 19 F 18 NS 4 
18. M 52 24 NS 11 F 20 NS 6 
19. M 55 25 NS 6 F 32 S 9 
20. M 59 32 S 23 F 24 NS 6 
21. F 60 30 S 19 F 40 S 13 
∑     289    90 
Average (x)     14.5    4.5 
STDV (s)     5,51    3,52 
V (%)     38,07    78,15 
sx     1,230 
 
   0,786 
 
sx2     1,514 
 
   0,619 
 
934                                                                                                             GENETIKA, Vol. 47, No.3, 927-939, 2015 
evidence of increased MN frequencies in patients with thyroid disorder, compared to healthy 
population. So many factors like age, gender, smoking etc. can cause MN frequency variation, but 
gender is one of the main factor estimated in many studies,  which confirmed that MN 
frequencies are higher in women than in men (FENECH, 1998; BOLOGNESI, 2002) generally by 1.2 
to 1.6 times (BOLOGNESI, 2002). This was explained by over-prevalence of X chromosome in the 
female organism (CATALAN et al., 1998; HANDO, 1997). 
The observed MN frequencies were compared with the criteria for spontaneous MNi 
(4.4±2.6 per 500 BN cells) given by FENECH and MORLEY (1985, 1986). The authors confirme 
than in the exposed group, 12 individual samples (60 %) showed an increase in the MN frequency 
while in the control group, the increased frequency of MNi was found in 1 of the blood samples 
(5%). 10 subjects with increased MN frequency in the exposed group and 1 in the control group 
smoked tobacco. In other words, this study revealed that the increased number of MNi in the 
exposed group was more common in smokers. Moreover, the clear evidence of increased number 
of MN formation was in a smoking woman in the control group. In addition to age and gender, 
smoking habits may change the MN frequency. The very important factors which explain the 
evidence of MN in the lymphocytes are the years of the exposure and the age of the subjects, 
especially in the exposed group. The samples with long time of exposure on ionizing radiation 
have much more MNi than the other samples (Table 2). In both analyzed samples of women in 
the exposed and the control group, age represents serious factor for the MNi values. BONASSI et 
al. (2003) confirmed a significant effect of smoking on MN frequency but, the study’s of HESSEL 
et al. (2001) and COSTA et al. (2006) observed no relation between smoking habit and MN 
frequency. EL-ZEIN, et al. (2008) and GARAJ-VRHOVAC et al. (2008) assessed that genotoxic 
hazards from cigarettes cause cell changes or cell death. Although men dominated in the exposed 
group, all the women from this exposed group showed increased MN frequency (Table 2). In the 
control group, one subject with increased MN frequency was a woman. The results of the other 
study’s (FENECH, 1994) that also used CBMN assay, suggest that sex is an important factor for 
evaluation of the cytogenetic damage. The authors of the study, also found an enormously high 
frequency of MNi in control women in comparison with men in the same group. One woman in 
the control group (at age 40) used ordinary therapy on oral estrogen hormones for two years 
before the test and she had increased number of MN in the lymphocytes (Table 2). The fact that 
the frequency of MNi is greater in female with reproductive disorders is confirmed in another 
study (FENECH, 1994), that also indicated greater chromosomal instability in lymphocytes. Other 
study’s (THIERENS et al., 1999; 2000; JOSEPH et al., 2009) also assessed that the frequencies of 
MN are greater in females than in males. In this study the authors confirmed that two men in the 
exposed group, who have hypothyroidism (receive a therapy with euthyrox), have increased 
number of MNi (Table 2). In the research of AL FAISAL et al. (2012), there was an evidence of 
increased MN frequencies in patients with thyroid disorder, compared to healthy population. So 
many factors like age, gender, smoking etc. can cause MN frequency variation, but gender is one 
of the main factor estimated in many studies,  which confirmed that MN frequencies are higher in 
women than in men (FENECH, 1998; BOLOGNESI, 2002) generally by 1.2 to 1.6 times (BOLOGNESI, 
2002). This was explained by over-prevalence of X chromosome in the female organism 
(CATALAN et al., 1998; HANDO, 1997). 
Sometimes a trinucleated cell can resemble a BN cell with MN, which occurs when one 
of the nuclei is relatively small, but still is greater than 1/3 of the other nuclei. This cell should not 
be scored as MNi originated from chromosome loss or breakage. Similar distracting cells can be 
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found when there is dense stippling in a specific region of the cytoplasm, or when a NBUD has a 
narrow connection to the nucleus, so it appears like an MN or when nuclear blebs have no 
obvious constriction or bridge among them and the nucleus (FENECH, 2000). They represent a 
constant connection between the two nuclei in a BN cell and their origin is from dicentric 
chromosomes whose centromeres were dragged to the opposite poles of separating cells. 
Micronucleus frequency in the BN cells is compatible (or well-matched) biomarker on mutagen 
or cytostatic effects of different agents on human cells (BONASSI et al., 2011; EL-ZEIN et al., 2011; 
KOCAMAN et al., 2008;). Also, this frequency can represent an indicator for chromosome damage, 
instability and can assess the risk of cancer, acquired mutations and genetic susceptibility 
(FENECH, 2000; JOSEPH et al., 2009). The difference of MN occurrence between males and 
females, smokers and non-smokers in both exposed and control group can be consequence to 
isolated exposure of some member of the group to non-specified genotoxic agent. Oxidative stress 
can also be a huge contributing factor for increased MN frequencies which can lead up to 
infertility. This was shown by other author by performing analysis of MN numbers in correlation 
to oxidative stress intensity (BONASSI, 2007).   
In four blood samples of exposed subjects (men exposed on ionizing radiation more than 
20 years) in their lymphocytes, the authors found NPBs (Fig.5 a and b), and NBUDs (Fig.6a and 
b), (17). NBUDS are considered to have same structure as an MN, but they differ from them with 
the fact that they are linked to the nucleus by a narrow or wide stalk of nucleoplasmic material. 
The size of the link is dependent by the stage of the budding process which occurs during the S 
phase of the cell cycle. Examples of cellular structures that resemble MNi, but should not be 
classified as MNi, originating from chromosome breakage or loss are illustrated in Fig. 6. 
Sometimes, amplification of genes can cause formation of NBUDS (FENECH, 2000), after that 
when they detach from the nucleus they start to form a MN, a process specific for the S phase 
(SHIMIZU, et al., 1998).  The ‘‘cytome’’ concept includes that the cells are scored cytologically 
due to their possibility situation like necrosis, or apoptosis, its mitotic status (mononucleated, BN, 
multinucleated) and its genetic instability (presence of MNi, NPBs, NBUDs) (FENECH, 2007). The 
rate of chromosomal changes during the cell cycle often is described as chromosomal instability. 
When this chromosomal instability is evident in lymphocytes then it can be linked with various 
human health issues (FENECH, 1998). In all the studies on MN formation the authors recognize 
four mechanisms of MN formation, apoptosis like controlled cell death, disappearance of whole 
chromosomes during cell division, disappearance of acentric fragments during cell division and 
structural chromosomal changes. Different genotoxicological agents cause different MN 
formation, for example clastogenic agents usually induce the formation of smaller micronuclei 
while aneugenic agents induce the larger MN formation (HEDDLE, 1991; TUCKER, 1996). 
 
CONCLUSIONS 
Mutagenic substances are widely spread in the work environment, so from this point of 
view, cytogenetics provides numerous methods and assays for observation of the genotoxiclogical 
effects of these physical and chemical agents. One of the biomarkers in genotoxicology, for 
assessing the chromosomal instability and damage is scoring of MN frequency’s in lymphocytes, 
particularly for the observation of the chronic exposure of organisms to a potentially genotoxic 
agents, like ionizing radiation. The author’s results show that the mean of MN frequencies in the 
exposed group is greater in comparison with the mean of MN frequencies in the controlled group, 
also the greater number of MN in female subjects with reproductive disorders indicated greater 
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chromosomal instability in lymphocytes. These results suggest that chromosomal instability is in 
correlation with MN frequencies in medical workers exposed to ionizing radiation. The formation 
of small and large MNi, NPBs, NBUDs etc. indicates that medical workers are exposed on 
clastogenic and aneugenic agents, like ionizing radiation and have chromosomal instability and 
high risk of cancer. This study has a practical importance because it indicates the necessity of 
introducing a permanent genotoxicological and other monitoring on the vulnerable category of 
workers (in this study medical workers) who would contribute to better protection in this 
segment. The multidisciplinary elaboration of the topic, suggests the needs for a more serious 
approach to this important phenomenon (genotoxicological impact of ionizing radiation), 
application of other molecular cytogenetic techniques which allow easy detection of the rate of 
chromosome rearrangements and the origin of the chromosome instability.  
 
List of abbreviations: 
ANS                                        Abnormal nuclear shapes                             
CBMN                                     Cytokinesis-blocked micronucleus  
DNA                                        Deoxyribonucleic acid 
BN     Binucleated 
MN    Micronucleus     
MNi                                         Micronuclei 
NBUDs                                     Nuclear buds 
NPBs                                       Nucleoplasmic bridges 
PBL                                         Peripheral blood lymphocytes 
S/NS                                         Smoker/Nonsmoker 
M/F                                          Male/Female  
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Izvod 
Cilj ovih istraživanja je bio izučavanje genotoksičnosti jonizujućeg zračenja kod medicinskog 
osoblja koristeći mikronukleus – analizu. Istraživanja su vršena radi utvrđivanja rizika zračenjem 
na ljudsko zdravlje. Student’s t-test pokazuje značajne statistčke razlike između ukupnog broja 
binukleotidnih ćelija sa mikronukleusima unutar dve grupe (ozračene i kontrolna grupa) (t=6,812; 
p<0,05). Prosečna MN učestalost u ozračenoj grupi se povećava u poređenju sa prosečnom 
učestalošću u kontrolnoj grupi. Formiranje malih i velikih mikronukleusa ukazuje da medicinsko 
osoblje izloženo zračenju na random mestu ima hromozomalnu nestabilnost i rizik od pojave 
kancera.  
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